Updates are available Correction dated 2024-10-11
Click to view Correction: https://doi.org/10.1038/s41409-024-02418-9
-
Authors
Ogimi, Chikara https://orcid.org/0000-0002-2166-8152
Xie, Hu
Waghmare, Alpana https://orcid.org/0000-0003-2268-9470
Jerome, Keith R. https://orcid.org/0000-0002-8212-3789
Leisenring, Wendy M. https://orcid.org/0000-0001-7405-0906
Ueda Oshima, Masumi https://orcid.org/0000-0003-2277-1976
Carpenter, Paul A.
Englund, Janet A.
Boeckh, Michael
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (K23AI139385)
Seattle Children’s Research Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA15704, CA18029)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL081595, K24HL093294)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
- License Information
-
More Information
Article History
Received: 27 September 2021
Revised: 18 December 2021
Accepted: 10 January 2022
First Online: 16 February 2022
Change Date: 11 October 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41409-024-02418-9
Competing interests
: AW reports grant support from Ansun Biopharma, Allovir, VB Tech, Amazon, Inc, GlaxoSmithKline and Pfizer, and is an Advisory Board Member for Kyorin Pharmaceutical. JAE reports grant support from AstraZeneca, Merck, Pfizer, GlaxoSmithKline and Novavax, is an Advisory Board Member and consultant for Sanofi Pasteur, and is a consultant for Meissa Vaccines. MB reports grant support from Amazon, GSK, Regeneron, Janssen, Gilead and VirBio; he is a consultant for Allovir, Janssen, Gilead, ReViral and VirBio, and an Advisory Board Member for Evrys Bio (option to purchase shares). All other authors report no potential conflicts. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
